Prevalence and impact of vasomotor symptoms due to menopause among women in Canada: A subgroup analysis from an international cross-sectional survey of Women with Vasomotor Symptoms Associated with Menopause (WARM Study)
In a survey conducted in Canada, moderate/severe VMS were reported by 14.7% of postmenopausal women and were associated with impairment in quality of life, work productivity, daily activities, and sleep in perimenopausal and postmenopausal women.
Authors
- Carol Rea
- Lora Todorova (ORCID: https://orcid.org/0000-0002-5667-5707)
- Nesé Yuksel (ORCID: https://orcid.org/0000-0002-5154-7490)
- Ludmila Scrine
- Céline Bouchard (ORCID: https://orcid.org/0000-0003-2258-058X)
Institutions
- University of Alberta (CA)
- IQVIA (United Kingdom) (GB)
- Astellas Pharma (United Kingdom) (GB)
- Quebec - Clinical Research Organization in Cancer (CA)
Publication Details
- Journal
- Menopause The Journal of The North American Menopause Society
- Published
- 2024-12-27
- DOI
- https://doi.org/10.1097/gme.0000000000002451
- Citations
- 3
- Primary Topic
- Menopause: Health Impacts and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.07
Funders
- Pfizer
- Eisai
- Astellas Pharma
- Astellas Foundation for Research on Metabolic Disorders
- Bayer Canada
- Pfizer Canada